In addition to that, knocking down SOX2 in HNSCC CSCs deprives them of their self-renewal ability, chemoresistance (resulting from ABCG2 suppression), invasion capacity, and tumorigenicity in vivo [38]. This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.